{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:48:43Z","timestamp":1783572523804,"version":"3.55.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2021 Id 25726"],"award-info":[{"award-number":["IG 2021 Id 25726"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bbcan.2023.189019","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T05:13:24Z","timestamp":1699593204000},"page":"189019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Finding the junction between claudins and endometrial carcinoma"],"prefix":"10.1016","volume":"1878","author":[{"given":"Davide","family":"Capoferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Bignotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ravaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Mitola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2023.189019_bb0005","series-title":"Trends in Biochemical Sciences","first-page":"141","article-title":"The Claudins: From tight junctions to biological systems","author":"Tsukita","year":"2019"},{"issue":"4","key":"10.1016\/j.bbcan.2023.189019_bb0010","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.90264.2008","article-title":"Biology of claudins","volume":"295","author":"Angelow","year":"2008","journal-title":"American J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbcan.2023.189019_bb0015","series-title":"Tight Junction Structure and Function Revisited. Trends in Cell Biology","first-page":"805","author":"Otani","year":"2020"},{"issue":"7","key":"10.1016\/j.bbcan.2023.189019_bb0020","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1083\/jcb.141.7.1539","article-title":"Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin","volume":"141","author":"Furuse","year":"1998","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189019_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.physiol.68.040104.131404","article-title":"Claudins and epithelial Paracellular transport","volume":"68","author":"Van Itallie","year":"2006","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbcan.2023.189019_bb0030","series-title":"Mouse Nephron Segments","article-title":"Differential Expression Patterns of Claudins, Tight Junction Membrane Proteins","author":"Kiuchi-Saishin","year":"2002"},{"issue":"8","key":"10.1016\/j.bbcan.2023.189019_bb0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/09513590802242694","article-title":"Differential expression of claudins in human endometrium and endometriosis","volume":"24","author":"Gaetje","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.bbcan.2023.189019_bb0040","article-title":"Claudins in human cancer: a review","volume":"83-90","author":"Ouban","year":"2010","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.bbcan.2023.189019_bb0045","doi-asserted-by":"crossref","first-page":"9603","DOI":"10.1158\/0008-5472.CAN-05-2782","article-title":"Claudin proteins in human cancer: promising new targets for diagnosis and therapy","author":"Morin","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2023.189019_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-physiol-012110-142150","article-title":"Tight junction pore and leak pathways: a dynamic duo","volume":"73","author":"Shen","year":"2011","journal-title":"Annu. Rev. Physiol."},{"issue":"49","key":"10.1016\/j.bbcan.2023.189019_bb0055","doi-asserted-by":"crossref","first-page":"24600","DOI":"10.1073\/pnas.1913346116","article-title":"Cell adhesion signals regulate the nuclear receptor activity","volume":"116","author":"Sugimoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189019_bb0060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"G\u00fcnzel","year":"2013","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189019_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcp.24687","article-title":"EGF regulates claudin-2 and -4 expression through Src and STAT3 in MDCK cells","volume":"230","author":"Garc\u00eda-Hern\u00e1ndez","year":"2015","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189019_bb0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.imbio.2017.10.016","article-title":"TLR2 activation induced by H. Pylori LPS promotes the differential expression of claudin-4, \u22126, \u22127 and \u22129 via either STAT3 and ERK1\/2 in AGS cells","volume":"223","author":"Chavarr\u00eda-Vel\u00e1zquez","year":"2018","journal-title":"Immunobiology."},{"issue":"5","key":"10.1016\/j.bbcan.2023.189019_bb0075","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1053\/j.gastro.2004.07.022","article-title":"Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease","volume":"127","author":"Hadj-Rabia","year":"2004","journal-title":"Gastroenterology."},{"issue":"21","key":"10.1016\/j.bbcan.2023.189019_bb0080","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.3390\/ijms20215396","article-title":"A novel claudinopathy based on claudin-10 mutations","volume":"20","author":"Milatz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2023.189019_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(01)00200-8","article-title":"Mutations in the gene encoding tight junction Claudin-14 cause autosomal recessive deafness DFNB29","volume":"104","author":"Wilcox","year":"2001","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.bbcan.2023.189019_bb0090","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1172\/JCI26323","article-title":"Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16","volume":"116","author":"Jaya Kausalya","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbcan.2023.189019_bb0095","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1086\/508617","article-title":"Mutations in the tight-junction gene Claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement","volume":"79","author":"Konrad","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.bbcan.2023.189019_bb0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.biopsych.2021.01.015","article-title":"Brain DNA methylation patterns in CLDN5 associated with cognitive decline","volume":"91","author":"H\u00fcls","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbcan.2023.189019_bb0105","series-title":"Claudin-5: Gatekeeper of Neurological Function. Fluids and Barriers of the CNS","author":"Greene","year":"2019"},{"key":"10.1016\/j.bbcan.2023.189019_bb0110","series-title":"Dysregulated Expression of Claudins in cancer (Review)","author":"Li","year":"2021"},{"key":"10.1016\/j.bbcan.2023.189019_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01441","article-title":"Claudin family participates in the pathogenesis of inflammatory bowel diseases and colitis-associated colorectal Cancer","volume":"10","author":"Zhu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2023.189019_bb0120","first-page":"12","article-title":"The role and mechanism of claudins in cancer","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189019_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell."},{"issue":"5","key":"10.1016\/j.bbcan.2023.189019_bb0130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"issue":"10","key":"10.1016\/j.bbcan.2023.189019_bb0135","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1242\/jcs.00389","article-title":"Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins\/occludin by snail","volume":"116","author":"Ikenouchi","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2023.189019_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","article-title":"EMT, the cytoskeleton, and cancer cell invasion","author":"Yilmaz","year":"2009","journal-title":"Cancer Metastasis Rev."},{"issue":"5","key":"10.1016\/j.bbcan.2023.189019_bb0145","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.fertnstert.2007.11.095","article-title":"Altered expression of claudin-3 and claudin-4 in ectopic endometrium of women with endometriosis","volume":"91","author":"Pan","year":"2009","journal-title":"Fertil. Steril."},{"issue":"26","key":"10.1016\/j.bbcan.2023.189019_bb0150","doi-asserted-by":"crossref","first-page":"18446","DOI":"10.18632\/oncotarget.24858","article-title":"Claudin3 is localized outside the tight junctions in human carcinomas","volume":"9","author":"Corsini","year":"2018","journal-title":"Oncotarget."},{"issue":"10","key":"10.1016\/j.bbcan.2023.189019_bb0155","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/j.1349-7006.2007.00569.x","article-title":"Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells","volume":"98","author":"Osanai","year":"2007","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.bbcan.2023.189019_bb0160","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer genomics portal: an open platform for exploring multidimensional Cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"10.1016\/j.bbcan.2023.189019_bb0165","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbcan.2023.189019_bb0170","series-title":"The Evolution of Endometrial Carcinoma Classification through Application of Immunohistochemistry and Molecular Diagnostics: Past, Present and Future","first-page":"885","author":"Goebel","year":"2018"},{"key":"10.1016\/j.bbcan.2023.189019_bb0175","series-title":"Two Pathogenetic Types of Endometrial Carcinoma","author":"Bokhman","year":"1983"},{"issue":"3","key":"10.1016\/j.bbcan.2023.189019_bb0180","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0046-8177(00)80244-0","article-title":"PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases","volume":"31","author":"Bussaglia","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2023.189019_bb0185","series-title":"Loss of ARID1A Expression Correlates with Stages of Tumor Progression in Uterine Endometrioid Carcinoma","author":"Mao","year":"2013"},{"issue":"9","key":"10.1016\/j.bbcan.2023.189019_bb0190","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1634\/theoncologist.2015-0149","article-title":"The therapeutic challenge of targeting HER2 in endometrial Cancer","volume":"20","author":"Diver","year":"2015","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.bbcan.2023.189019_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10717-z","article-title":"PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer","volume":"7","author":"Mjos","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbcan.2023.189019_bb0200","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/modpathol.2017.15","article-title":"CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence","volume":"30","author":"Kurnit","year":"2017","journal-title":"Mod. Pathol."},{"issue":"9387","key":"10.1016\/j.bbcan.2023.189019_bb0205","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(03)14342-5","article-title":"L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas","volume":"362","author":"Fogel","year":"2003","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.bbcan.2023.189019_bb0210","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/PGP.0b013e3181cd6552","article-title":"High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes","volume":"29","author":"Alkushi","year":"2010","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"7447","key":"10.1016\/j.bbcan.2023.189019_bb0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Getz","year":"2013","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189019_bb0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2023.189019_bb0225","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/annonc\/mdy058","article-title":"Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series","volume":"29","author":"Kommoss","year":"2018","journal-title":"Ann. Oncol."},{"issue":"21","key":"10.1016\/j.bbcan.2023.189019_bb0230","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.3390\/cancers14215429","article-title":"Integrated biomarker analysis reveals L1CAM as a potential stratification marker for no specific molecular profile high-risk endometrial carcinoma","volume":"14","author":"Ravaggi","year":"2022","journal-title":"Cancers."},{"issue":"6220","key":"10.1016\/j.bbcan.2023.189019_bb0235","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189019_bb0240","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ygyno.2006.04.005","article-title":"Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma","volume":"103","author":"Sobel","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2023.189019_bb0245","first-page":"6776","article-title":"Downregulation of lipolysis-stimulated lipoprotein receptor promotes cell invasion via claudin-1-mediated matrix metalloproteinases in human endometrial cancer","volume":"14","author":"Shimada","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189019_bb0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00418-020-01876-8","article-title":"ASPP2 suppression promotes malignancy via LSR and YAP in human endometrial cancer","volume":"154","author":"Konno","year":"2020","journal-title":"Histochem. Cell Biol."},{"issue":"11","key":"10.1016\/j.bbcan.2023.189019_bb0255","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s43032-020-00230-6","article-title":"Possibility of targeting Claudin-2 in therapy for human Endometrioid endometrial carcinoma","volume":"27","author":"Okada","year":"2020","journal-title":"Reprod. Sci."},{"issue":"6","key":"10.1016\/j.bbcan.2023.189019_bb0260","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1074\/jbc.M116.762807","article-title":"Down-regulation of claudin-2 expression and proliferation by epigenetic inhibitors in human lung adenocarcinoma A549 cells","volume":"292","author":"Hichino","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2023.189019_bb0265","first-page":"6","article-title":"The claudin gene family: Expression in normal and neoplastic tissues","author":"Hewitt","year":"2006","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2023.189019_bb0270","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/sj.bjc.6602480","article-title":"Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy","volume":"92","author":"Santin","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2023.189019_bb0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1525-1438.2006.00748.x","article-title":"Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue","volume":"17","author":"Pan","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"11","key":"10.1016\/j.bbcan.2023.189019_bb0280","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1158\/1078-0432.CCR-06-3037","article-title":"Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas","volume":"13","author":"Santin","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2023.189019_bb0285","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.22536","article-title":"Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE)","volume":"109","author":"Santin","year":"2007","journal-title":"Cancer."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189019_bb0290","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2008.01.024","article-title":"Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer","volume":"109","author":"Konecny","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.189019_bb0295","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3892\/ol.2013.1198","article-title":"Overexpression of claudin-4 may be involved in endometrial tumorigenesis","volume":"5","author":"Pan","year":"2013","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.bbcan.2023.189019_bb0300","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/IGC.0b013e318272ab12","article-title":"Altered claudin-4 expression in progesterone-treated endometrial adenocarcinoma cell line Ishikawa","volume":"22","author":"Pan","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2023.189019_bb0305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00441-013-1676-9","article-title":"Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano","volume":"354","author":"Someya","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbcan.2023.189019_bb0310","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.2147\/OTT.S174618","article-title":"Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K\/AKT\/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B","volume":"11","author":"Cao","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"10","key":"10.1016\/j.bbcan.2023.189019_bb0315","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers12102748","article-title":"Prognostic significance of aberrant Claudin-6 expression in endometrial Cancer","volume":"12","author":"Kojima","year":"2020","journal-title":"Cancers."},{"issue":"7","key":"10.1016\/j.bbcan.2023.189019_bb0320","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1158\/1541-7786.MCR-20-0835","article-title":"Aberrant Claudin-6\u2013adhesion signaling promotes endometrial Cancer progression via estrogen receptor \u03b1","volume":"19","author":"Kojima","year":"2021","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2023.189019_bb0325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3892\/ol.2013.1330","article-title":"Downregulation of claudin-7 potentiates cellular proliferation and invasion in endometrial cancer","volume":"6","author":"Li","year":"2013","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.bbcan.2023.189019_bb0330","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3892\/ijo.2022.5425","article-title":"Claudin-9 is a novel prognostic biomarker for endometrial cancer","volume":"61","author":"Endo","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2023.189019_bb0335","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cancers13040906","article-title":"The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features","volume":"13","author":"Romani","year":"2021","journal-title":"Cancers."},{"issue":"3","key":"10.1016\/j.bbcan.2023.189019_bb0340","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85902","article-title":"Claudin-low bladder tumors are immune infiltrated and actively immune suppressed","volume":"1","author":"Kardos","year":"2016","journal-title":"JCI Insight."},{"key":"10.1016\/j.bbcan.2023.189019_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00047","article-title":"Molecular and clinical characterization of a Claudin-low subtype of gastric Cancer","volume":"1","author":"Nishijima","year":"2017","journal-title":"JCO Precis. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2023.189019_bb0350","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"Prat","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbcan.2023.189019_bb0355","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3389\/fonc.2020.01287","article-title":"Low expression of Claudin-7 as potential predictor of distant metastases in high-grade serous ovarian carcinoma patients","volume":"10","author":"Romani","year":"2020","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2023.189019_bb0360","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1878-0261.12082","article-title":"The EMT spectrum and therapeutic opportunities","volume":"11","author":"Voon","year":"2017","journal-title":"Mol. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2023.189019_bb0365","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/ijms21020569","article-title":"Claudin-1, a double-edged sword in cancer","volume":"21","author":"Bhat","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2023.189019_bb0370","article-title":"Identification of Claudin-6 as a molecular biomarker in Pan-Cancer through multiple omics integrative analysis","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2023.189019_bb0375","series-title":"Clinical Actionability of Molecular Targets in Endometrial cancer. Nature Reviews Cancer","first-page":"510","author":"Urick","year":"2019"},{"issue":"1","key":"10.1016\/j.bbcan.2023.189019_bb0380","doi-asserted-by":"crossref","first-page":"70.e1","DOI":"10.1016\/j.ajog.2009.02.010","article-title":"Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas","volume":"201","author":"Romani","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"33","key":"10.1016\/j.bbcan.2023.189019_bb0385","doi-asserted-by":"crossref","first-page":"34617","DOI":"10.18632\/oncotarget.5315","article-title":"Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery","volume":"6","author":"Romani","year":"2015","journal-title":"Oncotarget."},{"issue":"11","key":"10.1016\/j.bbcan.2023.189019_bb0390","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1158\/1078-0432.CCR-22-2981","article-title":"Preclinical Efficacy of the Antibody\u2013Drug Conjugate CLDN6\u201323-ADC for the Treatment of CLDN6-Positive Solid Tumors","volume":"29","author":"McDermott","year":"2023","journal-title":"Clin. Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X23001683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X23001683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T04:34:06Z","timestamp":1719894846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X23001683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0304419X23001683"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2023.189019","relation":{"is-supplemented-by":[{"id-type":"uri","id":"https:\/\/proteinatlas.org\/","asserted-by":"subject"}]},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Finding the junction between claudins and endometrial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2023.189019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189019"}}